Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v21-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2022-09-23 | 2021-07-28 |
Drug Identification Number | 02244931 | 02244931 |
Brand name | MESNA FOR INJECTION | MESNA FOR INJECTION |
Common or Proper name | Mesna for Injection 100 mg/mL MD Vial 10 mL | Mesna for Injection 100 mg/mL MD Vial 10 mL |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | MESNA | MESNA |
Strength(s) | 100MG | 100MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL | 10 mL |
ATC code | V03AF | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-08-06 | 2021-08-06 |
Actual start date | 2021-08-06 | |
Estimated end date | 2022-12-01 | 2021-09-27 |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Mesna for Injection 100 mg/mL MD Vial 10 mL until December 1, 2022 | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay we will be anticipating a backorder on our Mesna for Injection 100 mg/mL MD Vial 10 mL effective August 6, 2021 until September 27, 2021. Baxter is an alternate supplier of Mesna for Injection and has been informed of our impending supply interruption. |
Health Canada comments |